BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 7750111)

  • 1. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A
    Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome aberrations in 35 primary ovarian carcinomas.
    Pejovic T; Heim S; Mandahl N; Baldetorp B; Elmfors B; Flodérus UM; Furgyik S; Helm G; Himmelmann A; Willén H
    Genes Chromosomes Cancer; 1992 Jan; 4(1):58-68. PubMed ID: 1377010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Mertens F; Johansson B; Höglund M; Mitelman F
    Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
    Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
    Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic findings in colorectal cancer mirror multistep evolution of colorectal cancer.
    Pirc-Danoewinata H; Bull JP; Okamoto I; Karner J; Breiteneder S; Liebhardt A; Budinsky A; Marosi C
    Wien Klin Wochenschr; 1996 Dec; 108(23):752-8. PubMed ID: 8990513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
    Genes Chromosomes Cancer; 1989 Nov; 1(2):167-71. PubMed ID: 2487157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotypic characterization of colorectal adenocarcinomas.
    Bardi G; Sukhikh T; Pandis N; Fenger C; Kronborg O; Heim S
    Genes Chromosomes Cancer; 1995 Feb; 12(2):97-109. PubMed ID: 7535093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H
    J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies of prostatic cancer.
    Lundgren R
    Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
    Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
    Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
    Mrózek K; Karakousis CP; Bloomfield CD
    Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom chromosome changes in malignant melanoma.
    Becher R; Gibas Z; Karakousis C; Sandberg AA
    Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
    Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
    Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities in human non-small cell lung cancer.
    Testa JR; Siegfried JM
    Cancer Res; 1992 May; 52(9 Suppl):2702s-2706s. PubMed ID: 1314134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.